Director Sun Kang’s family trust sells 217,869 Amprius (NYSE: AMPX) shares under 10b5-1 plan

Rhea-AI Filing Summary

Amprius Technologies director Sun Kang, through the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST, reported open-market sales of a total of 217,869 shares of common stock on March 23, 2026. The shares were sold in two tranches at average prices of $18.6863 and $19.0589, with individual trade prices ranging from $17.89 to $19.36. These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 18, 2025. Following the sales, the trust held 56,406 shares indirectly, while Kang also held 1,342,400 shares directly, including 1,159,385 restricted stock units subject to vesting conditions.

Insights

Equity governance analyst

Pre-planned sales by a director’s family trust look routine in scale.

Director Sun Kang, via a family revocable trust, sold 217,869 shares of Amprius Technologies common stock in open-market trades around $18.69 and $19.06 on March 23, 2026. The filing shows these trades were executed under a Rule 10b5-1 trading plan adopted on August 18, 2025, indicating they were pre-scheduled rather than opportunistic.

After the sales, the trust still held 56,406 shares indirectly, and Kang held 1,342,400 shares directly, including 1,159,385 restricted stock units that vest over time. This suggests the director retains a substantial equity stake. Given the pre-planned nature and remaining holdings, the activity appears as routine portfolio management rather than a major shift in insider sentiment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sun Kang

(Last) (First) (Middle)

C/O AMPRIUS TECHNOLOGIES, INC.,

1180 PAGE AVENUE

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Amprius Technologies, Inc. [ AMPX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	03/23/2026		S(1)		152,823	D	$18.6863(2)	121,452	I	See Footnote(3)
Common stock	03/23/2026		S(1)		65,046	D	$19.0589(4)	56,406	I	See Footnote(3)
Common stock								1,342,400(5)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.

2. The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $17.89 to $18.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

3. These securities are held directly by the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST, for which the reporting person and his spouse are co-trustees.

4. The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $18.89 to $19.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

5. Includes 1,159,385 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.

Remarks:

	/s/ Ricardo C. Rodriguez, attorney-in-fact on behalf of Kang Sun	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Amprius Technologies (AMPX) director Sun Kang report?

Director Sun Kang reported his family trust sold 217,869 shares of Amprius Technologies common stock on March 23, 2026, in open-market transactions at average prices of $18.6863 and $19.0589, according to a Form 4 insider trading report.

At what prices were the AMPX shares sold in Sun Kang’s March 2026 Form 4?

The reported sales occurred at average prices of $18.6863 and $19.0589 per share. Footnotes note individual trades ranged from $17.89 to $18.88 and from $18.89 to $19.36, reflecting multiple executions within each reported average price range.

Were Sun Kang’s AMPX share sales under a Rule 10b5-1 trading plan?

Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on August 18, 2025. Such pre-arranged plans schedule trades in advance and are often used to systematize insider selling and reduce concerns about trade timing.

How many Amprius Technologies shares did the family trust hold after the reported sales?

After the March 23, 2026 sales, the KANG & CECILLIA SUN FAMILY REVOCABLE TRUST held 56,406 Amprius Technologies common shares indirectly. These holdings are reported with Sun Kang and his spouse as co-trustees responsible for the trust’s positions in the company’s stock.

What are Sun Kang’s direct holdings in AMPX after the March 2026 Form 4?

The Form 4 shows Sun Kang directly held 1,342,400 Amprius Technologies common shares after the reported trades. This figure includes 1,159,385 restricted stock units, each representing a right to receive one share subject to vesting schedules and applicable conditions.

Does the Form 4 for AMPX indicate remaining derivative or option positions for Sun Kang?

The insider data associated with this Form 4 shows no remaining derivative positions such as options or warrants in the derivativeSummary. The reported holdings consist of common stock, including restricted stock units that vest over time rather than traditional stock options.